Blenrep for Multiple Myeloma Withdrawn From US Market
The manufacturer is pulling the drug from the market at the request of the FDA following disappointing results from a large phase 3 confirmatory trial.
Source: medscape.com
Page 20 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ar T Today - Breaking & Trending Today
Teclistamab for MM: Lifesaver or 'Cause of Death'?
Teclistamab (Tecvayli) has been approved for relapsed/refractory multiple myeloma patients who have received at least four lines of therapy; typically, such patients have just a few weeks to live.
Source: medscape.com
Novel Co-Admin of CAR T Cells Achieves 99% Remission in Leukemia
In the largest study to date of CAR T-cell therapy for relapsed and refractory childhood B-cell acute lymphoblastic leukemia, a novel approach led to undetectable disease in nearly all patients.
Source: medscape.com
Study finds treatment options for patients whose blood cancer relapses after CAR-T
Researchers from Memorial Sloan Kettering Cancer Center (MSK) and Mount Sinai have uncovered treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
Source: webindia123.com
Researchers find treatment options for patients whose blood cancer relapses after CAR-T
Researchers from Memorial Sloan Kettering Cancer Center (MSK) and Mount Sinai have uncovered treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
Source: webindia123.com